Thursday, June 26, 2025, 12:30-1:30 pm ET
Time: 3:00 p.m. – 4:00 p.m. GMT
Overview of facts, tips and resources to help Canadian healthcare practitioners cope with increased occupational stress, anxiety and substance use during COVID-19. Topics covered include advice on how to manage stress and anxiety as well as…
Reports on a study examining common misconceptions about cannabis held by youth, where gaps in evidence-based information exist and how best to move forward with cannabis prevention efforts.
Ottawa, September 27, 2024 — As we commemorate the National Day for Truth and Reconciliation and Orange Shirt Day and as an ally, the Canadian Centre on Substance Use and Addiction strives to work with First Nations, Inuit and…
Summarizes the increased risk of accidental overdose due to xylazine in Canada’s unregulated drug supply. Xylazine is a non-opioid pain reliever developed as a sedative and muscle relaxant for animals. It is being found as an adulterant in other…
Summarizes the results of consultations with key informants across jurisdictions on the challenges of collecting and reporting data on substance use treatment.
Ottawa, August 13, 2018 — Cannabis legalization in Canada is less than 75 days away. What can we expect when this happens?
This report summarizes the findings of a six-week online public consultation held in spring 2021 to inform an update of Canada’s Low-Risk Alcohol Drinking Guidelines. It outlines what we heard from more than 4,800 people in Canada, as well as…
Submitted to Health Canada in April 2022.
Presents the latest clinical evidence on cannabis use and impaired driving among Canadians.
Intended for policy and decision makers working in health, technology, social services, and diversity and inclusion, this brief outlines six recommendations for ways to improve access to and experiences with virtual substance use care for equity-…
